Pecorella Irene, La Cava Maurizio, Mannino Giuseppe, Pinca Marco, Pezzi Paola Pivetti
Department of Experimental Medicine and Pathology, University of Rome, Rome, Italy.
Acta Ophthalmol Scand. 2006 Apr;84(2):263-5. doi: 10.1111/j.1600-0420.2005.00571.x.
A 34-year-old man presented with anterior scleral thinning in the right eye (RE) and a painful nodular scleritis in the left eye (LE). Fundus examination showed a healed vasculitis and an inferior epiretinal neovascular membrane in the LE. Topical and systemic oral steroids and antiviral medication were prescribed. One year later, optic disc hyperaemia and swelling and macular oedema became apparent in the LE. Pulsed intravenous steroids were administered for 1 year, when a nasal septum perforation and vitreous haemorrhage in the LE were diagnosed. The eye was enucleated 3.5 years after the initial complaint. Necrotizing granulomatous tissue replacing the sclera and subconjunctival granulomatous tissue were observed. Six months later, oedema and neovascularization of the right optic disc were observed and cyclophosphamide was started, with regression of the clinical signs. No systemic abnormalities have so far become apparent.
Posterior scleritis is most often observed in patients with no signs of associated systemic autoimmune disease. The diagnosis in this case is most probably one of Wegener's granulomatosis (WG). In WG, the diagnosis is based on necrotizing granulomas of the respiratory tract, generalized focal necrotizing vasculitis and focal necrotizing glomerulonephritis. Eye involvement with WG has been reported in up to 58% of cases. Evaluation of the scleritis patient should include a detailed medical history, chest X-rays, blood tests, autoantibody serology and analysis of urinary sediment. Cyclophosphamide is the treatment of choice for patients with ocular manifestations of WG, polyarteritis nodosa or rheumatoid arthritis, either alone or in combination with systemic steroids. Visual loss is expected in 85% of individuals with severe necrotizing posterior scleritis.
一名34岁男性,右眼(RE)出现前巩膜变薄,左眼(LE)患有疼痛性结节性巩膜炎。眼底检查显示左眼有愈合的血管炎和下方视网膜前新生血管膜。给予局部和全身口服类固醇及抗病毒药物治疗。一年后,左眼出现视盘充血、肿胀及黄斑水肿。给予脉冲静脉注射类固醇治疗1年,此时诊断出左眼鼻中隔穿孔和玻璃体积血。在初次就诊3.5年后,该眼被摘除。观察到坏死性肉芽肿组织取代了巩膜以及结膜下肉芽肿组织。6个月后,观察到右眼视盘水肿和新生血管形成,开始使用环磷酰胺治疗,临床症状消退。目前尚未发现全身异常。
后巩膜炎最常出现在无相关系统性自身免疫疾病体征的患者中。该病例最可能的诊断是韦格纳肉芽肿(WG)。在WG中,诊断基于呼吸道的坏死性肉芽肿、全身性局灶性坏死性血管炎和局灶性坏死性肾小球肾炎。据报道,高达58%的WG病例会累及眼部。对巩膜炎患者的评估应包括详细的病史、胸部X线检查、血液检查、自身抗体血清学检查以及尿沉渣分析。对于有WG、结节性多动脉炎或类风湿关节炎眼部表现的患者,环磷酰胺是首选治疗药物,可单独使用或与全身类固醇联合使用。85%患有严重坏死性后巩膜炎的患者预计会出现视力丧失。